Estimating the social cost of respiratory cancer cases attributable to occupational exposures in France
详细信息 查看全文
- 作者：Hassan Serrier (1)
Hélène Sultan-Taieb (1) (2)
Danièle Luce (3) (4)
Sophie Bejean (1) - 关键词：Cost ; Occupational health ; Respiratory tract neoplasms ; Asbestos ; Cost of illness ; D61 ; H51 ; H55 ; I18 ; J24 ; J28 ; J32
- 刊名：The European Journal of Health Economics
- 出版年：2014
- 出版时间：July 2014
- 年：2014
- 卷：15
- 期：6
- 页码：661-673
- 全文大小：
- 参考文献：1. Kogevinas, M., Pearce, N., Susser, M., Boffetta, P.: Social inequalities and cancer. IARC Sci. Publ. 138, 1-5 (1997)
2. Imbernon, E.: Quelle place pour les risques professionnels dans la santé publique? Sante. Publique. 20(3), S9–S17 (2008) CrossRef
3. Barnay, T., Briard, K.: Carrière incomplète et départ en retraite : Une estimation de l’incidence de l’état de santé à partir de données individuelles. Revue économique 60(2), 345-63 (2009). Paris. 1950 CrossRef
4. Debrand, T., Lengagne, P.: Working conditions and health of European older workers. Institut de Recherche et de Documentation en économie de la Santé, Paris (2008)
5. Stokes, M.E., Ishak, J., Proskorovsky, I., Black, L.K., Huang, Y.: Lifetime economic burden of prostate cancer. BMC Health Servi. Res. 11, 349 (2011). doi:10.1186/1472-6963-11-349 CrossRef
6. Berkowitz, N., Gupta, S., Silberman, G.: Estimates of the lifetime direct costs of treatment for metastatic breast cancer. Value Health 3(1), 23-0 (2000). doi:10.1046/j.1524-4733.2000.31003.x CrossRef
7. Lamerato, L., Havstad, S., Gandhi, S., Jones, D., Nathanson, D.: Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data. Cancer 106(9), 1875-882 (2006). doi:10.1002/cncr.21824 CrossRef
8. Weissflog, D., Matthys, H., Hasse, J., Virchow Jr, J.C.: Epidemiology and costs of lung cancer in Germany. Pneumologie Stuttgart, Germany 55(7), 333-38 (2001). doi:10.1055/s-2001-15618 CrossRef
9. Rao, S., Kubisiak, J., Gilden, D.: Cost of illness associated with metastatic breast cancer. Breast Cancer Res. Treat. 83(1), 25-2 (2004). doi:10.1023/b:brea.0000010689.55559.06 CrossRef
10. Sorensen, S.V., Goh, J.W., Pan, F., Chen, C., Yardley, D., Martin, M., Knopf, K., Benedict, A., Giorgetti, C., Iyer, S.: Incidence-based cost-of-illness model for metastatic breast cancer in the United States. Int. J. Technol. Assess. Health Care 28(1), 12-1 (2012). doi:10.1017/s026646231100064x CrossRef
11. Song, X., Zhao, Z., Barber, B., Gregory, C., Cao, Z., Gao, S.: Cost of illness in patients with metastatic colorectal cancer. J. Medical Econ. 14(1), 1- (2011). doi:10.3111/13696998.2010.536870 CrossRef
12. Thom, T.J.: Economic costs of neoplasms, arteriosclerosis, and diabetes in the United States. In vivo 10(2), 255-59 (1996)
13. Fahs, M.C., Markowitz, S.B., Leigh, J.P., Shin, C.G., Landrigan, P.J.: A national estimate of the cost of occupationally related disease in 1992. Ann. N. Y. Acad. Sci. 837, 440-55 (1997) CrossRef
14. Leigh, J.P., Yasmeen, S., Miller, T.R.: Medical costs of fourteen occupational illnesses in the United States in 1999. Scand. J. Work Environ. Health 29(4), 304-13 (2003) CrossRef
15. Leigh, J.P.: Economic burden of occupational injury and illness in the United States. Milbank Q. 89(4), 728-72 (2011) CrossRef
16. Gomez, Garcia: M., Urbanos Garrido, R., Castaneda Lopez, R., Lopez Menduina, P.: [Direct health care costs of lung and bladder cancer attributable to work. Spain, 2008]. Revista espanola de salud publica 86(2), 127-38 (2012). doi:10.1590/s1135-57272012000200002 CrossRef
17. Biddle, J., Roberts, K., Rosenman, K.D., Welch, E.M.: What percentage of workers with work-related illnesses receive workers-compensation benefits? J. Occup. Environ. Med. 40(4), 325-31 (1998) CrossRef
18. Leigh, J.P., Robbins, J.A.: Occupational disease and workers-compensation: coverage, costs, and consequences. Milbank Q. 82(4), 689-21 (2004). doi:10.1111/j.0887-378X.2004.00328.x CrossRef
19. Bonauto, D.K., Smith, C.K., Adams, D.A., Fan, Z.J., Silverstein, B.A., Foley, M.P.: Language preference and non-traumatic low back disorders in Washington State workers-compensation. Am. J. Ind. Med. 53(2), 204-15 (2010). doi:10.1002/ajim.20740 CrossRef
20. Fayad, R., Nuwayhid, I., Tamim, H., Kassak, K., Khogali, M.: Cost of work-related injuries in insured workplaces in Lebanon. Bull. World Health Organ. 81(7), 509-16 (2003)
21. Del Sol, M., Turquet, P.: La branche ? accidents du travail et maladies professionnelles ? ou les difficultés de socialisation du risque professionnel. Econ. Appl. 60(1), 153-80 (2007)
22. Kasbi Benassouli, V., Imbernon, E., Iwatsubo, Y., Buisson, C., Goldberg, M.: Confrontation des cancérogènes avérés en milieu de travail et des tableaux de maladies professionnelles. In. Institut de veille sanitaire, (2005)
23. Siemiatycki, J., Richardson, L., Straif, K., Latreille, B., Lakhani, R., Campbell, S., Rousseau, M.C., Boffetta, P.: Listing occupational carcinogens. Environ. Health Perspect. 112(15), 1447-459 (2004) CrossRef
24. Fingerhut, M., Driscoll, T., Nelson, D.I., Concha-Barrientos, M., Punnett, L., Pruss-Ustin, A., Steenland, K., Leigh, J., Corvalan, C.: Contribution of occupational risk factors to the global burden of disease: a summary of findings. Scand. J. Work Environ. Health 1(suppl), 59-1 (2005)
25. Nelson, D.I., Concha-Barrientos, M., Driscoll, T., Steenland, K., Fingerhut, M., Punnett, L., Pruss-Ustun, A., Leigh, J., Corvalan, C.: The global burden of selected occupational diseases and injury risks: methodology and summary. Am. J. Ind. Med. 48(6), 400-18 (2005) CrossRef
26. Driscoll, T., Takala, J., Steenland, K., Corvalan, C., Fingerhut, M.: Review of estimates of the global burden of injury and illness due to occupational exposures. Am. J. Ind. Med. 48(6), 491-02 (2005) CrossRef
27. Steenland, K., Burnett, C., Lalich, N., Ward, E., Hurrell, J.: Dying for work: the magnitude of US mortality from selected causes of death associated with occupation. Am. J. Ind. Med. 43(5), 461-82 (2003) CrossRef
28. Nurminen, M., Karjalainen, A.: Epidemiologic estimate of the proportion of fatalities related to occupational factors in Finland. Scand. J. Work Environ. Health 27(3), 161-13 (2001) CrossRef
29. t’Mannetje, A., Pearce, N.: Quantitative estimates of work-related death, disease and injury in New Zealand. Scand. J. Work Environ. Health 31(4), 266-76 (2005) CrossRef
30. Imbernon, E., Goldberg, M., Marchand J, L., Gilg Soit Ilg, A., Carton, M.: Estimation du nombre de cas de cancers attribuables à des facteurs professionnels. Archives des maladies professionnelles et de médecine du travail 64(6) (2003)
31. Albin, M., Magnani, C., Krstev, S., Rapiti, E., Shefer, I.: Asbestos and cancer: an overview of current trends in Europe. Environ. Health Perspect. 107(Suppl 2), 289-98 (1999) CrossRef
32. Autier, P., Boffetta, P., Boniol, M., Boyle, P., Ferlay, J., Aurengo, A., Masse, R., De Thé, G., Monier, R., Tubiana, M., Valleron, A.J., Hill, C.: Attributable causes of cancer in France in the year 2000. International Agency for Research on Cancer, (2007) p 177
33. Bejean, S., Sultan-Ta?eb, H.: Modeling the economic burden of diseases imputable to stress at work. Eur J Health Econ 50(1), 16-3 (2005) CrossRef
34. Leigh, J.P., Markowitz, S.B., Fahs, M., Shin, C., Landrigan, P.J.: Occupational injury and illness in the United States. Estimates of costs, morbidity, and mortality. Arch. Intern. Med. 157(14), 1557-568 (1997) CrossRef
35. Leigh, J.P., Cone, J.E., Harrison, R.: Costs of occupational injuries and illnesses in California. Prev. Med. 32(5), 393-06 (2001) CrossRef
36. Leigh, J.P.: Expanding research on the economics of occupational health. Scand. J. Work Environ. Health 32(1), 1- (2006) CrossRef
37. Drummond, M., Sculpher, M., Torrance, G.: Methods for the economic evaluation of health care programmes, vol. 3. Oxford University Press, Oxford (2005)
38. Drummond, M.: Cost-of-illness studies: a major headache? pharmaco Econ. 2(1), 1- (1992) CrossRef
39. Goldberg, M., Imbernon, E., Rolland, P., Gilg Soit Ilg, A., Saves, M., de Quillacq, A., Frenay, C., Chamming’s, S., Arveux, P., Boutin, C., Launoy, G., Pairon, J.C., Astoul, P., Galateau-Salle, F., Brochard, P.: The French national mesothelioma surveillance program. Occup. Environ. Med. 63(6), 390-95 (2006). doi:10.1136/oem.2005.023200 CrossRef
40. Lacourt, A., Brochard, P., Houot, M.: Présentation d’une matrice emplois-expositions aux fibres d’amiante Quelques applications à un échantillon de population en France. In., p. 6p. Institut de Veille Sanitaire, Saint-Maurice, (2010)
41. Pilorget, C., Dananche, B., Luce, D., Fevotte, J.: éléments techniques sur l’exposition professionnelle aux carburants et solvants pétroliers. Matrice emplois-expositions aux carburants et solvants pétroliers. Institut de Veille Sanitaire, Saint-Maurice, (2007) p. 21
42. Luce, D., Fevotte, J., Institut de Veille Sanitaire. Saint-Maurice, FRA: Le programme Matgéné. Matrices emplois-expositions en population générale. état d’avancement-septembre 2005. Enquête. Institut de Veille Sanitaire, Saint-Maurice (2006)
43. Delabre, L., Pilorget, C., Garras, L., Fevotte, J., Groupe de travail Matgéné, F.R.A.: éléments techniques sur l’exposition professionnelle aux poussières alvéolaires de silice cristalline libre. Présentation d’une matrice emplois-expositions aux poussières alvéolaires de silice cristalline libre. Institut de Veille Sanitaire, Saint-Maurice (2010)
44. Arnaudo, B., Floury, M.C., Guignon, N., Magaud-Camus, I., Sandret, N., Vinck, L., Waltisperger, D.: Les expositions aux risques professionnels, les produits chimiques : résultats SUMER 2003. In. DARES document d’études n°118, (2006)
45. DADS: Déclaration Annuelle de Données Sociales - postes et salariés - 2008. Available from: http://www.insee.fr/fr/themes/detail.asp?reg_id=0&ref_id=fd-dads2008. Accessed 2012
46. Invs, Inca: Projection de l’incidence et de la mortalité par cancer en France en 2010. Institut de veille sanitaire, Saint-Maurice (2010)
47. CEPIDC: Interrogation des données sur les causes de décès de 1979 à 2010. Centre d’épidémiologie sur les Causes Médicales de Décès. Available from: http://www.cepidc.inserm.fr/inserm/html/index2.htm. Accessed 2012
48. Colonna, M., Danzon, A., Delafosse, P., Mitton, N., Bara, S., Bouvier, A.M., Ganry, O., Guizard, A.V., Launoy, G., Molinie, F., Sauleau, E.A., Schvartz, C., Velten, M., Grosclaude, P., Tretarre, B.: Cancer prevalence in France: time trend, situation in 2002 and extrapolation to 2012. Eur. J. Cancer 44(1), 115-22 (2008). doi:10.1016/j.ejca.2007.10.022 CrossRef
49. Molinier, L., Combescure, C., Chouaid, C., Daures, J.P., Housset, B., Fabre, D., Grand, A., Vergnenegre, A.: Cost of lung cancer: a methodological review. In: Pharmacoeconomics, vol. 24. vol. 7, pp. 651-59. New Zealand (2006)
50. Tarricone, R.: Cost-of-illness analysis. What room in health economics? Health Policy 77(1), 51-3 (2006). doi:10.1016/j.healthpol.2005.07.016 CrossRef
51. Amalric, F.: Analyse économique des co?ts du cancer en France. Impact sur la qualité de vie, prévention, dépistage, soins, recherche. In. Institut National du Cancer, Boulogne-Billancourt, (2007)
52. Borella, L., Peuvrel, P., Sauvage, M., Maraninchi, D., Philip, T.: Un essai d’exploitation de la base PMSI nationale pour évaluer le volume et les modes de prise en charge du cancer en secteur hospitalier non lucratif. Revue d’épidémiologie et de santé publique 48(1), 53-0 (2000)
53. Borella, L., Finkel, S., Crapeau, N., Peuvrel, P., Sauvage, M., Perrier, L., Lepage, E., Villeminot, J., Garrigues, B.: Volume et co?t de la prise en charge hospitalière du cancer en France en 1999. Bull. Cancer 89(9), 809-21 (2002)
54. ATIH: Principaux résultats issus des données de co?ts ENCC 2011. In. Agence Technique de l’Information sur l’Hospitalisation, (2013)
55. Jegou, J.J.: Rapport d’information fait au nom de la commission des finances sur les missions d’intérêt général et d’aide à la contractualisation (MIGAC). In., p. 63. Sénat-Session ordinaire 2010-011, (2010)
56. Mourlat, B., Gathion, S., Nowak, F., Hoog Labouret, N., Institut National du Cancer. Paris, FRA.: Situation de la chimiothérapie des cancers en 2010. In., p. 38p. Inca, Boulogne-Billancourt, (2010)
57. Borella, L., Paraponaris, A.: Reconstitution macro-économique des dépenses, suivi micro-économique des co?ts du cancer du sein. Revue d’épidémiologie et de santé publique 50(6), 581-92 (2002)
58. Schultz, A.B., Edington, D.W.: Employee health and presenteeism: a systematic review. J. Occup. Rehabil. 17(3), 547-79 (2007). doi:10.1007/s10926-007-9096-x CrossRef
59. Malavolti, L., Mermillod, C., Bataille, P., Compagnon, C., Moatti, J.-P.: Situation professionnelle et difficultés économiques des patients atteints d’un cancer deux ans après le diagnostic. In: Résultats, D.E.E. (ed.). Direction de la recherche, des études, de l’évaluation et des statistiques, (2006)
60. Rice, D.P.: Estimating the cost of illness. Am. J. Public Health 57(3), 424-40 (1967) CrossRef
61. Koopmanschap, M.A., van Ineveld, B.M.: Towards a new approach for estimating indirect costs of disease. Social science and medicine (1982) 34(9), 1005-010 (1992)
62. Brouwer, W.B., Koopmanschap, M.A.: The friction-cost method: replacement for nothing and leisure for free? In: Pharmacoeconomics, vol. 23. vol. 2, pp. 105-11. New Zealand (2005)
63. Koopmanschap, M.A., Rutten, F.F., van Ineveld, B.M., van Roijen, L.: The friction cost method for measuring indirect costs of disease. In: J Health Econ, vol. 14. vol. 2, pp. 171-89. Netherlands (1995)
64. Oliva, J., Lobo, F., Lopez-Bastida, J., Zozaya, N., Romay, R.: Indirect costs of cervical and breast cancers in Spain. Eur J Health Econ 6(4), 309-13 (2005). doi:10.1007/s10198-005-0303-4 CrossRef
65. Goetzel, R.Z., Long, S.R., Ozminkowski, R.J., Hawkins, K., Wang, S., Lynch, W.: Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting US employers. In: J Occup Environ Med, vol. 46. vol. 4, pp. 398-412. United States (2004)
66. Roy, D.: La contribution du travail domestique au bien-être matériel des ménages : une quantification à partir de l’enquête Emploi du Temps. In. Direction des Statistiques Démographiques et Sociales de l’INSEE, (2011)
67. Roy, D.: Le travail domestique : 60 milliards d’heures en 2010. In: INSEE Première. INSEE, (2012)
68. Cnav: Les principaux chiffres du régime général au 31 décembre 2010. In. Direction Statistique et Prospection de la Caisse Nationale d’Assurance Vieillesse, (2011)
69. Chouaid, C., Molinier, L., Combescure, C., Daures, J.P., Housset, B., Vergnenegre, A.: Economics of the clinical management of lung cancer in France: an analysis using a Markov model. In: Br J Cancer, vol. 90. vol. 2, pp. 397-02. England (2004)
70. Vergnenègre, A., Molinier, L., Combescure, C., Daurès, J.P., Housset, B., Choua?d, C.: The cost of lung cancer management in France from the payor’s perspective. Dis. Manag. Health Outcomes 14(1), 55-7 (2006). doi:10.2165/00115677-200614010-00007 CrossRef
71. Weill, A., Chinaud, F., Vallier, N., Bourrel, R., Suarez, C., Cayla, M., Roussel, H., Salanave, B., Girot, J.Y., Ricordeau, P., Fender, P.: Allemand A (2005) Fréquence et co?ts des trente affections de longue durée de la région Midi-Pyrénées, année 2003. Revue médicale de l’assurance maladie 36(4), 273-87 (2003)
72. Goeree, R., O’Brien, B.J., Blackhouse, G., Agro, K., Goering, P.: The valuation of productivity costs due to premature mortality: a comparison of the human-capital and friction-cost methods for schizophrenia. Can. J. Psychiatry 44(5), 455-63 (1999)
73. Steenland, K., Loomis, D., Shy, C., Simonsen, N.: Review of occupational lung carcinogens. Am. J. Ind. Med. 29(5), 474-90 (1996). doi:10.1002/(sici)1097-0274(199605)29:5<474:aid-ajim6>3.0.co;2-m CrossRef
74. Armstrong, B., Hutchinson, E., Unwin, J., Fletcher, T.: Lung cancer risk after exposure to polycyclic aromatic hydrocarbons: a review and meta-analysis. Environ. Health Perspect. 112(9), 970-78 (2004) CrossRef
75. Bruske-Hohlfeld, I., Mohner, M., Pohlabeln, H., Ahrens, W., Bolm-Audorff, U., Kreienbrock, L., Kreuzer, M., Jahn, I., Wichmann, H.E., Jockel, K.H.: Occupational lung cancer risk for men in Germany: results from a pooled case-control study. Am. J. Epidemiol. 151(4), 384-95 (2000) CrossRef
76. Dionne, G., Lebeau, M.: Le calcul de la valeur statistique d’une vie humaine. In: Cahiers de recherche. 1041, CIRPEE, (2010)
77. Demers, P.A., Boffetta, P., Kogevinas, M., Blair, A., Miller, B.A., Robinson, C.F., Roscoe, R.J., Winter, P.D., Colin, D., Matos, E., et al.: Pooled reanalysis of cancer mortality among five cohorts of workers in wood-related industries. Scand. J. Work Environ. Health 21(3), 179-90 (1995) CrossRef
78. Boffetta, P., Autier, P., Boniol, M., Boyle, P., Hill, C., Aurengo, A., Masse, R., The, G., Valleron, A.J., Monier, R., Tubiana, M.: An estimate of cancers attributable to occupational exposures in France. J. Occup. Environ. Med. 52(4), 399-06 (2010). doi:10.1097/JOM.0b013e3181d5e355 CrossRef - 作者单位：Hassan Serrier (1)
Hélène Sultan-Taieb (1) (2)
Danièle Luce (3) (4)
Sophie Bejean (1)
1. Laboratoire d’économie et Gestion, P?le économie Gestion, Université de Bourgogne, 2 boulevard Gabriel, BP 26611, 21066, Dijon Cedex, France
2. Département organisation et ressources humaines, Centre de recherche interdisciplinaire sur la biologie, la santé, la société et l’environnement (CINBIOSE), école des sciences de la gestion, Université du Québec à Montréal (UQAM), 315, rue Sainte-Catherine Est, Montréal, Québec, H2X 3X2, Canada
3. Faculté de Médecine, Institut de Recherche en Santé, Environnement et Travail (INSERM U1085), Campus de Fouillole, BP 145, 97154, Pointe-à-Pitre, Guadeloupe, France
4. Centre de Recherche en épidémiologie et Santé des Populations (INSERM U1018), H?pital Paul Brousse, Bat. Inserm 15/16, 16 Avenue Paul Vaillant-Couturier, 94807, Villejuif Cedex, France - ISSN：1618-7601
文摘
Purpose The objective of this article was to estimate the social cost of respiratory cancer cases attributable to occupational risk factors in France in 2010. Methods According to the attributable fraction method and based on available epidemiological data from the literature, we estimated the number of respiratory cancer cases due to each identified risk factor. We used the cost-of-illness method with a prevalence-based approach. We took into account the direct and indirect costs. We estimated the cost of production losses due to morbidity (absenteeism and presenteeism) and mortality costs (years of production losses) in the market and nonmarket spheres. Results The social cost of lung, larynx, sinonasal and mesothelioma cancer caused by exposure to asbestos, chromium, diesel engine exhaust, paint, crystalline silica, wood and leather dust in France in 2010 were estimated at between 917 and 2,181 million euros. Between 795 and 2,011 million euros (87-2?%) of total costs were due to lung cancer alone. Asbestos was by far the risk factor representing the greatest cost to French society in 2010 at between 531 and 1,538 million euros (58-1?%), ahead of diesel engine exhaust, representing an estimated social cost of between 233 and 336 million euros, and crystalline silica (119-29 million euros). Indirect costs represented about 66?% of total costs. Conclusion Our assessment shows the magnitude of the economic impact of occupational respiratory cancers. It allows comparisons between countries and provides valuable information for policy-makers responsible for defining public health priorities.